BRITTANY BELL: Open Payments
NPI 1972047587 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 59 payments from 17 companies in 2025. Trend: 2023 $2,414 · 2024 $1,545 · 2025 $1,347
Food & beverage: $1,275Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $238 |
| ABBVIE INC. | 11 | $207 |
| Lilly USA, LLC | 4 | $193 |
| Incyte Corporation | 3 | $85 |
| Organon LLC | 6 | $84 |
| Arcutis Biotherapeutics, Inc. | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| UCB, Inc. | 3 | $66 |
| Galderma Laboratories, L.P. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
Products named: TREMFYA, SKYRIZI, EBGLYSS, OPZELURA, Zoryve, TALTZ, Bimzelx, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
